Buy more Compazine and Save more.

ROCKVILLE, Md., June 16, 2008–The U.S. Food and Drug
Administration today exercised its new authority under the Food and
Drug Administration Amendments Act of 2007 (FDAAA) to require
manufacturers of “conventional” antipsychotic drugs to make
safety-related changes to prescribing information, or labeling, to
warn about an increased risk of death associated with the off-label
…